Calico
South San Francisco, United States · Founded 2013 · $1.3B raised
- Headquarters
- South San Francisco, California
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- calicolabs.com
- Total Funding
- $1.3B
- Last Round
- $500.0M Corporate RoundJun 2018
- Rounds
- 3
About
Alphabet-backed biotechnology company researching biology of aging and developing interventions to extend human lifespan.
Summary
Calico is a Biotech company based in South San Francisco, United States, founded in 2013. It has raised $1.3B in total across 3 rounds, most recently a $500.0M Corporate Round round in Jun 2018. Investors include AbbVie Ventures, Google and Alphabet.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2018
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company